What the UK can learn from the speedy Israeli vaccine rollout
Analysis of data casts doubt on one-jab approach despite falling infection rates

Experts are picking over the findings of research into Israel’s Covid-19 vaccine rollout after Health Secretary Matt Hancock turned to his Israeli counterpart for tips from the country that is leading the immunisation race.
Hancock and Israeli Health Minister Yuli Edelstein have spoken to “share best practice and to up the pace” of Britain’s rollout, The Sun reports. The Israeli jabs campaign is being held up as an example worldwide, with one in four members of the population now having received a first dose.
The UK’s vaccines minister, Nadhim Zahawi, told ITV’s Good Morning Britain earlier this month that Downing Street had “learned the speed at which they vaccinate - about four minutes per patient”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“That’s the sort of target we want,” Zahawi said.
Israel is currently vaccinating around 1.44 people in every 100 each day, according to Oxford University tracking - the fastest vaccination rate in the world, followed by the United Arab Emirates on 1.11.
However, new research into Israel’s strategy of giving all members of the population the first jab before rolling out the second doses has cast some doubt over the levels of immunity being achieved.
Although initial data on the Pfizer/BioNTech vaccine led the UK’s Joint Committee on Vaccination and Immunisation to conclude that the first dose delivered 89% protection from day ten after being administered, the Israeli study suggests that this protection may be as low as 33%.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Despite these concerns, however, the data coming out Israel has raised hopes that vaccinations can curb Covid case rates effectively.
Business Insider reports that although the country is “nowhere near Covid-19 free”, the “seven-day and three-day moving averages of new cases have declined” in line with the rollout of the vaccine.
That success hasn’t come cheap though.
The Israeli government struck a deal with Pfizer to not only pay a premium price but also to “exchange citizens’ data for ten million doses of the coronavirus vaccine”, reports Politico.
Officials initially said that Israel was paying the equivalent of £22 per dose - more than twice the amount paid by Belgium, according to a pricing list inadvertently tweeted by the European nation’s secretary of state.
However, an Israeli Health Ministry official, Yaron Niv, said in a separate interview with state broadcaster Kan that each dose had cost his country the equivalent of £34 per jab.
Another factor credited for Israel’s speedy vaccines rollout is the country’s mandatory public health system, in which all patient records are fed into a nationwide digital network.
“An operation of such speed and scale could not have happened in a private health care system,” an unnamed senior nurse at a hospital in Tel Aviv told Politico.
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
Supreme Court upholds 'ghost gun' restrictions
Speed Read Ghost guns can be regulated like other firearms
By Rafi Schwartz, The Week US Published
-
Trump sets 25% tariffs on auto imports
Speed Read The White House says the move will increase domestic manufacturing. But the steep import taxes could also harm the US auto industry.
By Peter Weber, The Week US Published
-
'Americans deserve immigration officials who are transparent about what they do and why'
instant opinion 'Opinion, comment and editorials of the day'
By Anya Jaremko-Greenwold, The Week US Published
-
Five years on: How Covid changed everything
Feature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
By The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published